These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 29246098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.
    Amato A, Imbimbo BP, Falsini B.
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5636-5653. PubMed ID: 37401302
    [Abstract] [Full Text] [Related]

  • 4. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [Abstract] [Full Text] [Related]

  • 5. An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
    Chen Y, Yu J, Ge S, Jia R, Song X, Wang Y, Fan X.
    Invest Ophthalmol Vis Sci; 2024 Jun 03; 65(6):8. PubMed ID: 38837168
    [Abstract] [Full Text] [Related]

  • 6. Vision Outcomes for Pediatric Patients With Optic Pathway Gliomas Associated With Neurofibromatosis Type I: A Systematic Review of the Clinical Evidence.
    Thirunavu VM, Mohammad LM, Kandula V, Beestrum M, Lam SK.
    J Pediatr Hematol Oncol; 2021 May 01; 43(4):135-143. PubMed ID: 33480655
    [Abstract] [Full Text] [Related]

  • 7. Neurofibromatosis 1-associated optic pathway gliomas.
    Shofty B, Ben Sira L, Constantini S.
    Childs Nerv Syst; 2020 Oct 01; 36(10):2351-2361. PubMed ID: 32524182
    [Abstract] [Full Text] [Related]

  • 8. Optic Pathway Gliomas Secondary to Neurofibromatosis Type 1.
    Beres SJ, Avery RA.
    Semin Pediatr Neurol; 2017 May 01; 24(2):92-99. PubMed ID: 28941532
    [Abstract] [Full Text] [Related]

  • 9. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.
    de Blank PMK, Fisher MJ, Liu GT, Gutmann DH, Listernick R, Ferner RE, Avery RA.
    J Neuroophthalmol; 2017 Sep 01; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346
    [Abstract] [Full Text] [Related]

  • 10. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E, Décarie JC, Marzouki M, Carret AS, Ospina LH.
    Pediatr Blood Cancer; 2014 Feb 01; 61(2):223-7. PubMed ID: 23956233
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.